Ingestible Balloon Helps Patients Lose Weight
|
By HospiMedica International staff writers Posted on 04 Oct 2016 |
|
Image: An ingestible intragastric balloon system helps reduce weight (Photo courtesy of Obalon).
An ingestible intragastric balloon system facilitates weight loss in obese adults who failed to lose weight through diet and exercise.
The Obalon system consists of a balloon folded inside a capsule that is swallowed by the patient, with no sedation or anesthesia required. Once the balloon reaches the stomach, it is remotely inflated via an attached micro-catheter that is subsequently removed, leaving behind a buoyant balloon with a volume of 250cc (about the size of a small orange) that weighs less than six grams. Over the following three months of treatment, two additional balloons are swallowed and inflated, bringing the total maximum displaced volume to750cc.
The nonsurgical weight loss system is fully reversible throughout the course, and at the end of the six-month treatment period, all three balloons are mandatorily removed via endoscopy under conscious sedation. The system is intended for use as an adjunct to a moderate intensity diet and to a behavior modification program. The Obalon balloon system is a product of Obalon (Carlsbad, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“We’re excited to bring this novel technology to the approximately 70 million adults in the United States who are struggling with obesity. For physicians, we believe that the Obalon technology represents an important new option for both their practices and their patients who are obese and looking to lose weight,” said Andy Rasdal, CEO of Obalon. “I’d also like to recognize the FDA for their efficient and interactive review of our product, which represents another option for physicians and patients in the battle against the obesity epidemic.”
“The clinical trial design for the Obalon balloon system was highly rigorous and the system demonstrated a favorable safety profile,” said Shelby Sullivan, MD, director of the gastroenterology bariatric and metabolic program at the University of Colorado School of Medicine (Aurora, USA). “We were also pleased to see that patients tolerated the administrations of the Obalon balloon remarkably well, with no recovery time needed. This is in contrast to other currently approved intragastric balloon devices, where most patients cannot immediately return to normal activities.”
Related Links:
Obalon
The Obalon system consists of a balloon folded inside a capsule that is swallowed by the patient, with no sedation or anesthesia required. Once the balloon reaches the stomach, it is remotely inflated via an attached micro-catheter that is subsequently removed, leaving behind a buoyant balloon with a volume of 250cc (about the size of a small orange) that weighs less than six grams. Over the following three months of treatment, two additional balloons are swallowed and inflated, bringing the total maximum displaced volume to750cc.
The nonsurgical weight loss system is fully reversible throughout the course, and at the end of the six-month treatment period, all three balloons are mandatorily removed via endoscopy under conscious sedation. The system is intended for use as an adjunct to a moderate intensity diet and to a behavior modification program. The Obalon balloon system is a product of Obalon (Carlsbad, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).
“We’re excited to bring this novel technology to the approximately 70 million adults in the United States who are struggling with obesity. For physicians, we believe that the Obalon technology represents an important new option for both their practices and their patients who are obese and looking to lose weight,” said Andy Rasdal, CEO of Obalon. “I’d also like to recognize the FDA for their efficient and interactive review of our product, which represents another option for physicians and patients in the battle against the obesity epidemic.”
“The clinical trial design for the Obalon balloon system was highly rigorous and the system demonstrated a favorable safety profile,” said Shelby Sullivan, MD, director of the gastroenterology bariatric and metabolic program at the University of Colorado School of Medicine (Aurora, USA). “We were also pleased to see that patients tolerated the administrations of the Obalon balloon remarkably well, with no recovery time needed. This is in contrast to other currently approved intragastric balloon devices, where most patients cannot immediately return to normal activities.”
Related Links:
Obalon
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiofrequency Generator
GX1
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Latest Critical Care News
- New Prediction Tool Supports Confident Prescribing of Heart Failure Medicines
- Machine Learning Models Identify Higher-Risk Pregnancies Earlier in Care
- Wearable Hormone Monitor Enables At-Home Detection of Primary Aldosteronism
- Contactless AI Tool Detects Hypertension and Diabetes from Facial Video
- AI Tool Predicts Bladder Cancer from Electronic Health Records
- Personalized Neuromodulation System Receives FDA Clearance for PTSD Treatment
- New Multimodal Framework Targets Debilitating Form of Heart Failure
- Telehealth-Enabled Paramedic Program Supports Post-Discharge Heart Failure Care
- AI Software Update Boosts Image Quality and Workflow for Portable MRI System
- New Polymer Electrode Extends Runtime of Needle-Free Drug Delivery Patches
- Ultrasound Technique Enables Arrhythmia Risk Assessment in Mitral Valve Disease
- 3D-Printed Membrane Could Enable Smaller, More Efficient Artificial Lungs
- Wearable Ultrasound Patch Uses AI to Detect Elevated Central Venous Pressure
- Switchable Soft Material Could Improve On-Demand Drug Delivery
- Smart Patch Could Detect Fentanyl and Deliver Automatic Overdose Aid
- AI Wearable Enables Continuous Noninvasive Arterial Blood Pressure Monitoring
Channels
Artificial Intelligence
view channel
AI Model Predicts Indwelling Catheter Use After Spinal Cord Injury
Patients with early-stage spinal cord injury and neurogenic bladder often face uncertain trajectories in urinary catheter management. Clinicians need tools to anticipate conversion to indwelling catheters... Read more
AI Tool Uses Mammograms to Detect Common Cardiovascular Diseases
Cardiovascular disease, encompassing hypertension, ischemic heart disease, and stroke, is the leading cause of death in women. Many cases are detected late, as symptoms can be subtle and routine screening... Read more
Surgical Techniques
view channel
Robotic System Aims to Expand Access to Stroke Thrombectomy
Ischemic stroke outcomes hinge on rapid access to endovascular thrombectomy, yet many eligible patients live far from comprehensive centers and miss critical treatment windows. Hospitals also face geographic... Read more
Biodegradable Gastric Stent Could Eliminate Repeat Procedures After Bariatric Surgery
Gastric leaks are a serious complication after weight-loss surgery that can lead to infection, prolonged hospitalization, and repeated interventions. Conventional drainage stents were designed for the... Read more
Patient Care
view channel
Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
Emergency department (ED) boarding—the practice of keeping admitted patients in the ED while awaiting an inpatient bed—creates hazardous delays in definitive care. Prolonged transitions expose older and... Read more
Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
Fluoroscopy-guided procedures expose clinicians to scatter radiation that accumulates over time, creating persistent occupational risks in cath labs and interventional suites. Traditional badges typically... Read more
Medical Imaging
view channel
Imaging-Guided Screening Could Identify Silent Atherosclerosis Earlier
Atherosclerosis, the arterial plaque buildup that drives most cardiovascular disease, often develops silently for decades. Undetected plaques in young adults can lead to preventable heart attacks and strokes... Read more
Study Links Thymus Radiation Dose to Poorer Outcomes in Lung Cancer
Collateral radiation to the thymus during therapy for non-small cell lung cancer (NSCLC) may compromise antitumor immunity and disease control. The thymus is a small immune organ in the upper chest that... Read more
Health IT
view channel
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read more
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Point of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read more
Business
view channel
First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
Transseptal access to the left atrium is critical in catheter-based cardiac procedures, where direct visualization and precise positioning are essential. Clinicians also aim to reduce fluoroscopy use and... Read more
